| Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN. | |
| | |
MedLine Citation:
|
PMID: 6889186 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
No effect of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN was observed. Low molecular weight peptides derived from fibrinogen degradation by plasmin (FDP) increase the motor activity of rats [7] augment apomorphine- and amphetamine-induced stereotypy and diminish haloperidol catalepsy [2]. It has been suggested that FDP interact with central dopamine receptor [2]. Taking the above considerations into account it was decided to investigate the effect of FDP on specific binding of [3H] spiroperidol and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene ([3H]ADTN). |
| | |
Authors:
|
W Buczko; A De Blasi |
Related Documents
:
|
2733696 - Characterization of the binding of [3h]l-365,260: a new potent and selective brain chol... 7849036 - Photoaffinity labeling and photoinactivation of the o2(-)-generating oxidase of neutrop... 9248666 - Competition of adenine nucleotides for a 1,3-[3h]-dipropyl-8-cyclopentylxanthine bindin... 3476116 - Tpa induces subcellular translocation and subsequent down-regulation of both phorbol es... 15006756 - Interaction of bacillus thuringiensis toxins with larval midgut binding sites of helico... 9360536 - Human thyroid peroxidase (tpo) isoforms, tpo-1 and tpo-2: analysis of protein expressio... |
Publication Detail:
|
Type: In Vitro; Journal Article |
Journal Detail:
|
Title: Polish journal of pharmacology and pharmacy Volume: 35 ISSN: 0301-0244 ISO Abbreviation: Pol J Pharmacol Pharm Publication Date: 1983 |
Date Detail:
|
Created Date: 1983-10-28 Completed Date: 1983-10-28 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0366561 Medline TA: Pol J Pharmacol Pharm Country: POLAND |
Other Details:
|
Languages: eng Pagination: 45-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Apomorphine / pharmacology Butyrophenones / metabolism* Dopamine / pharmacology Fibrin Fibrinogen Degradation Products / physiology* Male Molecular Weight Naphthalenes / metabolism* Rats Receptors, Dopamine / physiology Spiperone / metabolism* Tetrahydronaphthalenes / metabolism* |
| Chemical | |
Reg. No./Substance:
|
0/Butyrophenones; 0/Fibrin Fibrinogen Degradation Products; 0/Naphthalenes; 0/Receptors, Dopamine; 0/Tetrahydronaphthalenes; 53463-78-8/ADTN; 58-00-4/Apomorphine; 749-02-0/Spiperone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Phenylmercuric acetate and some hemostatic activities of rat platelets.
Next Document: Synthesis of perhydro-1,4-thiazepines, of expected pharmacological activity. Part III. 4-(2-hydroxye...